Dear Friends and Colleagues,
We are living in unprecedented times. The current pandemic
has had a major impact on all academic institutions including
the NIH. We had to stop recruitment of patients to the ME/CFS
study. However, we used this time as an opportunity to start
analyzing the data already collected on the patients recruited
thus far. At the same time we predicted early in the pandemic
that we would see an upsurge in new patients with ME/CFS
due to COVID-19. Even before people began to realize that
patients were developing overlapping symptoms with ME/CFS
which has been termed Long-Haul COVID we began
developing protocols to investigate these patients. These
protocols are now functional and we have started recruiting
patients to these studies. Additionally, I have taken this
opportunity to raise awareness of this condition and have
advocated for more research for the condition in numerous
interviews with major news outlets and in a testimony to the
Congressional Neuroscience Caucus. We remain strongly
committed to get to the bottom of this condition and we hope
that in the near future we will be planning clinical trials to treat
ME/CFS and Long-Haul COVID. Where there is a will, there is
way!
Best,
Avi